Behçet disease
Also known as: Behçet syndrome, Behçet's disease, Adamantiades–Behçet disease
Behçet disease is a relapsing inflammatory multisystem vasculitis characterised by mucosal ulceration (oral and genital) and cutaneous, ophthalmic, articular, vascular, neurological, and gastrointestinal involvement. Specialist management and immunosuppressive or anti-inflammatory pharmacotherapy are mandatory, particularly where organ-threatening sequelae are present. Chinese medicine functions solely as an adjunctive framework for symptomatic support and does not substitute for primary disease control. There is a lack of clinical acupuncture evidence for this condition. One small, open-label trial evaluated a modified herbal preparation as an adjunct for non-infectious anterior uveitis rather than Behçet disease specifically; these data are insufficient to establish efficacy for the formulas listed. Mechanistic research is not a substitute for clinical outcome data. Atypical progressive ulceration requires diagnostic reassessment.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a chronological record of mucosal ulceration, ophthalmic symptoms, arthralgia, bowel habit changes, and current medications for specialist review.
- •Practise meticulous oral hygiene using soft-bristled instruments; avoid acidic, spicy, or abrasive dietary triggers that may exacerbate active ulceration.
- •Establish consistent circadian rhythms and nutritional intake; pace physical activity around fatigue while avoiding prolonged unnecessary inactivity.
- •Adhere to all specialist consultations; consult the prescribing clinician regarding immunisation and infection prophylaxis. Prescribed medical therapies must not be ceased in favour of adjunctive interventions.
Cautions & Contraindications
- •Do not manage suspected active uveitis with acupuncture or herbs alone or delay ophthalmic treatment. Record 2 studied herbal treatment only alongside standard care and does not establish safety for Behçet-related posterior eye disease.[,]
- •Do not interpret temporary corticosteroid response or a TCM pattern as confirmation of Behçet disease. Enlarging ulcers, fever or gastrointestinal bleeding despite treatment require renewed diagnostic assessment before further adjunctive treatment.[]
- •Do not substitute the listed base formula for the studied modified preparation or assume equivalent safety. The small open-label uveitis trial cannot establish rare-event, pregnancy or drug-interaction safety.[]
When to reassess or seek care again
Establish baseline ulcer count and healing time, pain score from 0–10, sleep disruption, fatigue, stool frequency and functional impact. Review adjunctive tolerability within 1–2 weeks and measurable symptom benefit by 4 weeks; stop or revise if benefit is absent or adverse effects occur. Specialist examination, not symptom improvement alone, determines organ disease activity. New eye symptoms, bleeding or neurological or vascular symptoms trigger immediate referral rather than waiting for review.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- The Journal of rheumatology · 2026
- Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026
- Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
- The American journal of case reports · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
